Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Trial Not Allowed)
Key Information
Due Date: May 7, 2025
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: $581,371
Funding Type: Grant
Match Required: No
Contact Info:
OERWebmaster03@od.nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
The Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) grant program is designed to support research in pre-clinical stages that makes use of advanced methods in cancer biology. Specifically, the program aims to fund projects that explore how radiopharmaceutical therapy (RPT) agents affect the biology of normal tissues, tumor cells, and the tumor microenvironment. The ideal proposal should lay out plans for testing theories on how RPT dynamically influences cancer biology processes. These ideas could potentially serve as the groundwork in creating new strategies and methods targeting cancer cells. The insights generated from the research funded by this grant will play a pivotal role in creating the basis and design for new clinical trials centered around RPT therapy. However, it's important to note that this program does not allow for any actual clinical trial.
Show More
Key Dates
Open Date: March 18, 2022
Application Due Date: May 7, 2025
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses